The question often comes in the first serious investor conversation. “Did you develop any of this technology while you were at the university?”
How a founder answers determines whether diligence moves forward smoothly, or stalls.
Say you spent three years as a graduate student or postdoc, working in a university lab on research that eventually became the scientific foundation for a company. You leave the university, incorporate, build a pitch deck, and start taking investor meetings.
But the science that makes the company compelling also raises the question investors need resolved before they write a check.
Unclear university rights create delays that routinely push closes back by three to six months. You might see downward valuation pressure because investors price uncertainty into term sheets, with some investors reporting pre-money discounts of 15-25% or more when their IP provenance is unclear.
Unresolved claims can kill rounds entirely when founders can’t produce documentation showing clean ownership.
What creates university ownership claims
University ownership claims arise from three sources, and understanding them helps founders assess their own exposure before investors ask.
The first is employment or student agreements. Most universities require graduate students, postdocs, and faculty to sign agreements assigning inventions to the university. The specific language varies by institution, but the rule of thumb is that if you conceived or developed an invention while affiliated with the university, the university may own it or have rights to it. These agreements govern inventions conceived during your affiliation, regardless of when you leave. (The university's potential claims attach to timing of invention, not timing of departure.)
The second is use of university facilities, equipment, or resources. Even if your employment agreement is ambiguous, using university labs, materials, or computational resources to develop an invention can create university rights under institutional IP policies. This matters for founders who began working on company-related ideas while still affiliated, even if the formal incorporation happened later.
The third is federal funding. If your research involved government grants, the Bayh-Dole Act gives the university first rights to inventions arising from that funding. The university needs to retain title and file patents within specified timeframes, but the founder cannot simply assume federal funding didn’t create obligations. Bayh-Dole compliance is a separate diligence item that sophisticated investors understand well.
How investors evaluate university IP risk during diligence
Investors typically approach university IP with a three-part test:
- Can the company prove it owns the core IP?
- Did the founder disclose inventions to the university?
- Will undisclosed claims surface later to threaten the company’s freedom to operate?
What investors want to see is a clear narrative supported by documentation. They want to understand the timeline of invention development, what agreements governed your university relationship, whether you complied with disclosure obligations, and what the university’s position is on ownership. They’re not expecting perfection. They are expecting transparency, and evidence that you've engaged with the question seriously.
Research agreements that restrict freedom to operate
Separate from ownership claims, research agreements signed during your academic career can impose restrictions that affect commercial plans.
Material transfer agreements (MTAs), sponsored research agreements, and collaboration agreements may not give the university ownership of your inventions, but they can limit what you do with materials, methods, or data you accessed through those agreements.
Common restrictions include:
- Limitations on commercial use of transferred materials
- Publication timing requirements
- Derivative work provisions that extend restrictions to improvements or modifications
- Field-of-use limitations that carve out certain applications.
These restrictions can be narrow or broad depending on the specific agreement language.
In a hypothetical case similar to what we frequently see, a founder signed an MTA during graduate school to access a specialized cell line from another institution. The MTA permitted academic research but required separate commercial licensing for any commercial application, with a 90-day negotiation period before the company could use derivatives in its manufacturing process. Years later, that cell line became a core component of the company’s platform.
The founder assumed the MTA was an academic formality, but diligence revealed that commercial use required renegotiating terms with the providing institution. The resulting delay pushed the Series A close back by four months while the license was negotiated.
The issue wasn't ownership of the IP, but freedom to operate.
What clean documentation looks like
Investors need specific documentation to get comfortable with university IP. For ownership questions, you’ll need:
- A timeline showing when key inventions were conceived and reduced to practice relative to your university affiliation
- A copy of your university employment or student agreement with the invention assignment language highlighted
- Confirmation that you made required invention disclosures to the university, or an explanation of why none were required
- A letter from the tech transfer office confirming the university has no claims, or showing the license terms if university rights exist
A tech transfer office letter is the best option, and getting this letter before fundraising removes a diligence dependency from your timeline.
(Note: tech transfer processes vary significantly by institution. Stanford's Office of Technology Licensing operates on different timelines and with different priorities than a mid-tier research university’s office. This means it’s important to build your timeline realistically around the institution you're actually dealing with.)
Research agreements require a different kind of documentation. Founders should prepare an inventory of MTAs, sponsored research agreements, and collaboration agreements, with a summary of the restrictions each imposes. This inventory should include an explanation of how those restrictions affect commercial plans, or why they don’t, and evidence that material providers were notified of company formation where agreements required such notification.
The goal is to show investors that you’ve identified agreements that could affect freedom to operate and that you’ve assessed their commercial implications.
The paths forward when university claims are unclear
When university claims are ambiguous, founders have options, but each involves different tradeoffs in time, cost, and certainty.
If the underlying facts are favorable, the simplest path is documenting why no claim exists. This works when invention timing, agreement language, or policy interpretation supports the conclusion that the university has no ownership rights. A clear written analysis, ideally reviewed by counsel, can satisfy investors when the documentation is strong.
When university claims are legitimate, negotiating a license resolves the issue by defining the terms under which the company can use the IP. License negotiations typically take six months to over a year, depending on institutional complexity and the specific rights involved. Straightforward situations at responsive institutions can move faster; complex negotiations involving multiple inventions or contentious terms can extend well beyond a year. Your costs will include upfront fees, royalties, or equity. But a signed license removes uncertainty and gives investors a known quantity to evaluate.
A third option is obtaining a legal opinion explaining why university rights are unlikely. This works for situations where claims are theoretically possible but factually remote. A reasoned legal opinion from qualified counsel can sometimes provide investors enough comfort to proceed, but it carries less weight than documentation or executed licenses.
What founders should do before incorporating
Founders who document carefully (think: lab notebook with dated entries) during their university affiliation have dramatically easier fundraising conversations.
Start by understanding what your agreements assign. Read your employment or student agreement carefully, including any IP policy documents incorporated by reference. Know what triggers university ownership under your specific institutional framework.
Document invention timing carefully. Keep contemporaneous records of when ideas were conceived and when key experiments happened. This documentation becomes valuable if you later need to prove that commercially relevant inventions occurred after your affiliation ended.
Importantly, it’s best to avoid using university resources for company-related work after you've formed clear intent to commercialize. The line between academic research and commercial development can blur, but once you're thinking about a company, using university labs or equipment to advance that company creates unnecessary risk.
And consult the tech transfer office early and often. Many founders avoid tech transfer because they fear triggering university claims. In practice, engaging early often produces better outcomes than waiting for investors to surface questions you haven’t addressed.
In Summary
University IP questions will come up in your first serious investor conversation, and how you answer determines whether diligence moves forward or stalls.
Potential claims arise from three sources: employment or student agreements, use of university facilities, and federal funding under Bayh-Dole.
The critical variable in every case is timing: when key inventions were conceived and reduced to practice relative to your university affiliation.
Separately, research agreements like MTAs can restrict freedom to operate even when they don't create ownership claims.
Investors need documentation, not reassurance. Founders who can produce a clear timeline, the relevant agreements, and confirmation of the university's position remove friction that otherwise costs months and negotiating leverage.